Bacterial vaginosis
Conditions
Interventions
Premenopausal women aged 18 to 50 years, with cytology results indicating microbiota of supracytoplasmic bacilli, without complaints, will be included in the study after signing an informed consent fo
Sponsors
Leila Cristina Soares Brollo
Hospital Universitário Pedro Ernesto
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 18 to 50 years, in pre-menopause, with cytology result indicating supracytoplasmic bacilli microbiota, no complaints
Exclusion criteria
Exclusion criteria: pregnant women, postmenopausal women, with immunosuppressive diseases or using immunosuppressive medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess whether the use of probiotics in asymptomatic women with microbiota characteristic of bacterial vaginosis can, in the short term (immediately after termination), lead to changes in the characteristics of the microbiota, implying a predominance of lactobacilli. Evaluation will be made by collecting material for bacterioscopy with Nugent score and amine test, in addition to vaginal pH test. The Nugent score will be classified into BV (grater or equal 7), intermediate status (4 to 6) and healthy vaginal microbiota (less or equal 3). The amine test will be classified as positive or negative and the pH test will be presented in numerical values. We will observe if there was a change in the parameters evaluated after the use of the probiotic Lactobacillus rhamnosus HN001 109 CFU with Lactobacillus paracasei Lpc-37 109 CFU with Bifidobacterium lactis HN019 109 CFU orally for 30 days, through paired analyses. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected | — |
Countries
Brazil
Contacts
Public ContactLeila Brollo
Hospital Universitário Pedro Ernesto
Outcome results
None listed